
Bayogenin
CAS No. 6989-24-8
Bayogenin( —— )
Catalog No. M24715 CAS No. 6989-24-8
Bayogenin is an alfalfa saponin, Bayogenin shows moderate potency of glycogen phosphorylase inhibition.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 68 | In Stock |
![]() ![]() |
5MG | 115 | In Stock |
![]() ![]() |
10MG | 192 | In Stock |
![]() ![]() |
25MG | 322 | In Stock |
![]() ![]() |
50MG | 482 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBayogenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionBayogenin is an alfalfa saponin, Bayogenin shows moderate potency of glycogen phosphorylase inhibition.
-
DescriptionBayogenin is an alfalfa saponin, Bayogenin shows moderate potency of glycogen phosphorylase inhibition.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6989-24-8
-
Formula Weight488.7
-
Molecular FormulaC30H48O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@]([C@@]1([H])[C@]2(C[C@H](O)[C@@H]3O)C)(CC[C@@]2([H])[C@]3(C)CO)[C@@](C4=CC1)(CC[C@]5(C(O)=O)[C@@]4([H])CC(C)(C)CC5)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wray V , Kunath A , Sch?Pke T , et al. Bayogenin and asterogenic acid glycosides from Bellis perennis.[J]. Phytochemistry, 1992, 31(7):2555-2557.
molnova catalog



related products
-
Semilicoisoflavone B
Semilicoisoflavone B can inhibit sorbitol formation of rat lens incubated with a high concentration of glucose, indicates that it may be effective for preventing osmotic stress in hyperglycemia.
-
Adamantane
The adamantane moiety is the structural backbone of numerous compounds and the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry.
-
Bexmarilimab
Bexmarilimab (FP-1305) is a highly potent, humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM, promoting immune conversion of tumor-associated macrophage phenotype M2 to M1, and can be used to study cancer.